Hospital Pharmacy - May 2017 - 366

366

2.
3.
4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

Hospital Pharmacy 52(5)
apps.who.int/iris/bitstream/10665/67378/1/WHO_EDM_
QSM_2002.2.pdf. Published 2002. Accessed June 7, 2017.
Moore TJ, Psaty BM, Furberg CD. Time to act on drug safety.
JAMA. 1998;279(19):1571-1573.
Saha L. Role of pharmacovigilance in drug development.
Enliven Pharmacovigil Drug Saf. 2014;1(1):9-10.
Ponmari SJ, Sivaraman M, Aruna T, Subashree V. Knowledge
and awareness of pharmacovigilance among various medical
fraternities. Asian J Pharmacol Toxicol. 2015;03(10):45-48.
Vallano A, Cereza G, Pedròs C, et al. Obstacles and solutions
for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005;60(6):653-658.
Hohl CM, McGrail K, Sobolev B. The effect of pharmacistled medication review in high-risk patients in the emergency department: an evaluation protocol. CMAJ open. 2015
Jan;3(1):E103.
Aziz Z, Siang TC, Badarudin NS. Reporting of adverse
drug reactions: predictors of under-reporting in Malaysia.
Pharmacoepidemiol Drug Saf. 2007;16(2):223-228.
Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ.
Physicians' attitudes and adverse drug reaction reporting: a
case-control study in Portugal. Drug Saf. 2005;28(9):825-833.
Generali JA, Danish MA, Rosenbaum SE. Knowledge of and
attitudes about adverse drug reaction reporting among Rhode
Island pharmacists. Ann Pharmacother. 1995;29(4):365-369.
Valente S, Murray L, Fisher D. Nurses improve medication
safety with medication allergy and adverse drug reports. J Nurs
Care Qual. 2007;22(4):322-327.
Ahmad A, Patel I, Balkrishnan R, Mohanta GP, Manna PK. An
evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: a pilot study.
Perspect Clin Res. 2013;4(4):204-210.
Taché SV, Sönnichsen A, Ashcroft DM. Prevalence of adverse
drug events in ambulatory care: a systematic review. Ann
Pharmacother. 2011;45(7-8):977-989.
Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc.
1996;41(2):192-199.
Jericho BG, Tassone RF, Centomani NM, et al. An assessment
of an educational intervention on resident physician attitudes,
knowledge, and skills related to adverse event reporting. J
Grad Med Educ. 2010;2(2):188-194.

15. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug
reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-1205.
16. Qassim S, Metwaly Z, Shamsain M, Al Hariri Y. Reporting
adverse drug reactions: evaluation of knowledge, attitude
and practice among community pharmacists in UAE. IOSR J
Pharm. 2014;4(4):17-23.
17. Li Q, Zhang S, Chen H, et al. Awareness and attitudes of
healthcare professionals in Wuhan, China to the reporting of
adverse drug reactions. Chin Med J (Engl). 2004;117(6):856861.
18. Hardeep Bajaj JK, Rakesh K. A survey on the knowledge, attitude and the practice of pharmacovigilance among the health
care professionals in a teaching hospital in northern India. J
Clin Diagn Res. 2013;7(1):97-99.
19. McLernon DJ, Bond CM, Lee AJ, et al. Patient views and
experiences of making adverse drug reaction reports to the
Yellow Card Scheme in the UK. Pharmacoepidemiol Drug
Saf. 2011;20(5):523-531.
20. Okezie EO, Olufunmilayo F. Adverse drug reactions reporting
by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug
Saf. 2008;17:517-522.
21. Suyagh M, Farah D, Abu Farha R. Pharmacist's knowledge, practice and attitudes toward pharmacovigilance and
adverse drug reactions reporting process. Saudi Pharm J.
2014;23(2):147-153.
22. Hazell L, Cornelius V, Hannaford P, Shakir S, Avery AJ. How
do patients contribute to signal detection? a retrospective
analysis of spontaneous reporting of adverse drug reactions
in the UK's yellow card scheme. Drug Saf. 2013;36(3):199206.
23. Parretta E, Rafaniello C, Magro L, et al. Improvement of
patient adverse drug reaction reporting through a community
pharmacist-based intervention in the Campania region of Italy.
Expert Opin Drug Saf. 2014;13(suppl 1):S21-S29.
24. Vessal G, Mardani Z, Mollai M. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in
Iran. Pharm World Sci. 2009;31:183-187.
25. Van Grootheest AC, de Jong-van den Berg LTW. The role of
hospital and community pharmacists in pharmacovigilance.
Res Social Adm Pharm. 2005;1(1):12-33.


http://apps.who.int/iris/bitstream/10665/67378/1/WHO_EDM_QSM_2002.2.pdf http://apps.who.int/iris/bitstream/10665/67378/1/WHO_EDM_QSM_2002.2.pdf

Table of Contents for the Digital Edition of Hospital Pharmacy - May 2017

Editorial, For Sale: FDA Priority Review Vouchers
Current FDA-Related Drug Information; Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings
ISMP Adverse Drug Reactions: Levofloxacin-Induced Neuroexcitation and Hallucinations Statin-Induced Muscle Rupture Mefloquine-Induced Rhabdomyolysis Methimazole-Induced
Critical Care Pharmacist Market Perceptions: Comparison of Critical Care Program Directors and Directors of Pharmacy
Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer
Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients
Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention
Pharmacists’ Knowledge of the Cost of Laboratory Testing
Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers
Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital
Formulary Drug Reviews
Hospital Pharmacy - May 2017 - 317
Hospital Pharmacy - May 2017 - 318
Hospital Pharmacy - May 2017 - 319
Hospital Pharmacy - May 2017 - 320
Hospital Pharmacy - May 2017 - 321
Hospital Pharmacy - May 2017 - 322
Hospital Pharmacy - May 2017 - 323
Hospital Pharmacy - May 2017 - Editorial, For Sale: FDA Priority Review Vouchers
Hospital Pharmacy - May 2017 - 325
Hospital Pharmacy - May 2017 - Current FDA-Related Drug Information; Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
Hospital Pharmacy - May 2017 - Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings
Hospital Pharmacy - May 2017 - 328
Hospital Pharmacy - May 2017 - 329
Hospital Pharmacy - May 2017 - ISMP Adverse Drug Reactions: Levofloxacin-Induced Neuroexcitation and Hallucinations Statin-Induced Muscle Rupture Mefloquine-Induced Rhabdomyolysis Methimazole-Induced
Hospital Pharmacy - May 2017 - 331
Hospital Pharmacy - May 2017 - 332
Hospital Pharmacy - May 2017 - 333
Hospital Pharmacy - May 2017 - Critical Care Pharmacist Market Perceptions: Comparison of Critical Care Program Directors and Directors of Pharmacy
Hospital Pharmacy - May 2017 - 335
Hospital Pharmacy - May 2017 - 336
Hospital Pharmacy - May 2017 - 337
Hospital Pharmacy - May 2017 - 338
Hospital Pharmacy - May 2017 - 339
Hospital Pharmacy - May 2017 - 340
Hospital Pharmacy - May 2017 - Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer
Hospital Pharmacy - May 2017 - 342
Hospital Pharmacy - May 2017 - 343
Hospital Pharmacy - May 2017 - 344
Hospital Pharmacy - May 2017 - 345
Hospital Pharmacy - May 2017 - 346
Hospital Pharmacy - May 2017 - 347
Hospital Pharmacy - May 2017 - Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients
Hospital Pharmacy - May 2017 - 349
Hospital Pharmacy - May 2017 - 350
Hospital Pharmacy - May 2017 - 351
Hospital Pharmacy - May 2017 - 352
Hospital Pharmacy - May 2017 - Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention
Hospital Pharmacy - May 2017 - 354
Hospital Pharmacy - May 2017 - 355
Hospital Pharmacy - May 2017 - 356
Hospital Pharmacy - May 2017 - Pharmacists’ Knowledge of the Cost of Laboratory Testing
Hospital Pharmacy - May 2017 - 358
Hospital Pharmacy - May 2017 - 359
Hospital Pharmacy - May 2017 - 360
Hospital Pharmacy - May 2017 - Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers
Hospital Pharmacy - May 2017 - 362
Hospital Pharmacy - May 2017 - 363
Hospital Pharmacy - May 2017 - 364
Hospital Pharmacy - May 2017 - 365
Hospital Pharmacy - May 2017 - 366
Hospital Pharmacy - May 2017 - Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital
Hospital Pharmacy - May 2017 - 368
Hospital Pharmacy - May 2017 - 369
Hospital Pharmacy - May 2017 - 370
Hospital Pharmacy - May 2017 - 371
Hospital Pharmacy - May 2017 - 372
Hospital Pharmacy - May 2017 - 373
Hospital Pharmacy - May 2017 - Formulary Drug Reviews
Hospital Pharmacy - May 2017 - 375
Hospital Pharmacy - May 2017 - 376
Hospital Pharmacy - May 2017 - 377
Hospital Pharmacy - May 2017 - 378
Hospital Pharmacy - May 2017 - 379
Hospital Pharmacy - May 2017 - 380
Hospital Pharmacy - May 2017 - 381
Hospital Pharmacy - May 2017 - 382
Hospital Pharmacy - May 2017 - 383
Hospital Pharmacy - May 2017 - 384
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2019
http://www.nxtbook.com/nxtbooks/sage/fai_201909
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_july2019
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2019
http://www.nxtbook.com/nxtbooks/sage/canadianpharmacistsjournal_05062019
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2019
http://www.nxtbook.com/nxtbooks/sage/sri_supplement_201903
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2019
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2018
http://www.nxtbook.com/nxtbooks/sage/tec_20180810
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2018
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2018
http://www.nxtbook.com/nxtbooks/sage/fai_201807
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2018
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2018
http://www.nxtbook.com/nxtbooks/sage/sri_supplement_201803
http://www.nxtbook.com/nxtbooks/sage/slas_discovery_201712
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2018
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_november2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_september2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2017
http://www.nxtbook.com/nxtbooks/sage/fai_supplement_201709
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_may2017
http://www.nxtbook.com/nxtbooks/sage/fai_201706
http://www.nxtbook.com/nxtbooks/sage/fai_201607
http://www.nxtbookMEDIA.com